Request Trial
L-R: Ziyan ‘Frank’ Xue, Julie Park, David Tsai, Jenny Liu, Theresa Lee, and Zandir Morton, with K&L Gates in California and Texas.
15 September 2026NewsCareersLiz Hockley

K&L Gates hires six-strong team of IP and corporate lawyers from Pillsbury

The firm has strengthened its intellectual property, capital markets, corporate, transactional and litigation capabilities with the addition of the group, which will be based across California and Texas.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Week Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Atif Choudhury at achoudhury@lifesciencesipreview.com 


More on this story

Careers
Haynes Boone expands in California with new office
14 October 2026   Growing demand from life sciences and healthcare clients prompts an expansion in California, bringing the firm closer to biotechnology companies, research institutions and key courts for its Southern California litigators.
Careers
Brazilian firm appoints patent strategist to lead department
12 October 2026   Ouro Preto Paranhos has brought in a licensed pharmacist with more than 26 years of intellectual property experience to lead the patent practice at the Rio de Janeiro firm.
Careers
Latham adds ‘exceptional’ ITC expert and 5th trial lawyer in a year
6 October 2026   The new partner advises technology and life sciences companies in Section 337 investigations and related patent disputes, drawing on extensive private practice and government experience.


Editor's picks

Boston Scientific expands dispute with J&J unit over cardiac-access technology
MedTech
Boston Scientific expands dispute with J&J unit over cardiac-access technology
12 October 2026

Editor's picks

MedTech
Boston Scientific expands dispute with J&J unit over cardiac-access technology
12 October 2026
In-house counsel
WATCH: Genevant IP director on tackling UPC-EPO opposition divide
1 October 2026
Pharma
Lilly loses Fed Circ rehearing bid, sparking enablement questions
1 October 2026
Pharma
Takeda sees off UK challenge to Elvanse SPC
28 September 2026
Pharma
Behind the case: How Novartis defended its blockbuster Entresto in the UK
22 September 2026
Regulation & Industry
Inside the deal boom: LSIPR’s five-part M&A series—all in one place
17 September 2026

More features

Boehringer and Dr Reddy’s spar over plausibility as trial wraps up
Haynes Boone expands in California with new office
Accord’s generic hopes dashed in cyanide antidote ruling
Novo’s semaglutide protection weakens after European ruling
UK to clamp down on non-compete clauses and long notice periods
Boston Scientific expands dispute with J&J unit over cardiac-access technology
Brazilian firm appoints patent strategist to lead department
AIPPI World Congress: ‘Diversity need not be an obstacle to unity’